Missed rifampicin and isoniazid resistance by commercial molecular assays
Drug-resistant tuberculosis (TB) has poor outcomes unless resistance is detected early, ideally by commercially available molecular tests. We present a case of occult multidrug-resistant TB where both rifampicin and isoniazid resistance were missed by molecular testing and were only identified...
| Glavni autori: | , , , |
|---|---|
| Format: | Članak |
| Jezik: | English |
| Izdano: |
South African Medical Association
2024-07-01
|
| Serija: | South African Medical Journal |
| Teme: | |
| Online pristup: | https://samajournals.co.za/index.php/samj/article/view/1779 |